LQDA stock news · Liquidia
Get alerts for LQDA
Follow Liquidia (LQDA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LQDA12 health care stocks are changing a lot during Wednesday's trading.
NeutralLiquidia's shares rose 26.29% on Wednesday. The story gives no company update, so the move alone does not change the view of its business.
12 health care stocks are changing a lot before the market opens on Wednesday.
NeutralLiquidia shares rose 41% before Wednesday's market opened, but the article gives no company news behind the move. It does not change the company outlook.
Liquidia has ended a tough battle with United Therapeutics by agreeing to a $380.7 million settlement.
Good for LQDALiquidia settled 6 lawsuits, keeping YUTREPIA available for PAH. The large payment and lost PH-ILD use hurt, but continued sales and an end to the court fights make the news favorable.
Stock futures for the S&P 500 and Dow Jones are up as people wait for the September inflation report, with ASML, GME, and UNH getting attention.
Good for LQDALiquidia settled with United Therapeutics, ending all pending lawsuits. That removes a legal dispute, though the article gives no financial terms.
Big stocks like First Tracks Biotherapeutics, C3.ai, and CCC Intelligent Solutions jumped up on Monday.
NeutralLiquidia Corporation is listed among stocks that rose, but the story gives no company news explaining why. It does not change the outlook for the company.
Liquidia's stock keeps dropping after a U.S. court decision in a patent fight.
Bad for LQDAA court ruling found that Liquidia infringed 2 United Therapeutics patent claims over Yutrepia. Possible limits on the drug’s U.S. availability make the ruling unfavorable for Liquidia.
United Therapeutics' stock went up after a court ruled in its favor against Liquidia over a patent issue.
Bad for LQDALiquidia lost a key patent ruling, and the court rejected its claim that the patent was invalid. United Therapeutics is seeking to remove the lung condition from Liquidia’s drug label, but that change has not been ordered.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutralLiquidia shares fell 9.13%. The article reports a share move, not business news that changes the company's outlook.
Progress Software, Nft, and other major stocks dropped in value before the market opened on Thursday.
Bad for LQDAA court ruled that patent claims were valid and infringed by Liquidia. The ruling creates a setback for the company and its lead product.
Liquidia (LQDA) stock is getting attention after a court said it broke two patents.
Bad for LQDALiquidia lost on 2 patent claims tied to Yutrepia, and the court may limit its use. That threatens the business, despite Liquidia's plan to appeal.
Liquidia Corp: Other Events (LQDA)
NeutralLiquidia said United Therapeutics' case concerns a patent tied to YUTREPIA. The filing gives no court ruling or product-access change, so it does not show a change in Liquidia's outlook.
12 health care companies are seeing big changes in their stock prices today.
NeutralLiquidia shares fell 25% to $53.22. The article gives no company news explaining the move, so it does not change the business outlook.